Form 6-K Cuprina Holdings (Cayman For: Jun 15

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of June 2026

 

Commission File Number: 001-42288

 

Cuprina Holdings (Cayman) Limited

(Registrant’s Name)

 

c/o Blk 1090 Lower Delta Road #06-08

Singapore 169201

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

 

 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

 

On June 15, 2026, Cuprina Holdings (Cayman) Limited (the “Company”) issued a press release announcing receipt of clearance from the U.S. Food and Drug Administration (FDA) for MEDIFLY Maggots. This press release is furnished herewith as Exhibit 99.1.

 

Exhibit Index

 

Exhibit No.		Description
99.1		Press Release dated June 15, 2026

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	Cuprina Holdings (Cayman) Limited
	By:	/s/ David Quek Yong Qi
	Name:	David Quek Yong Qi
	Title:	Chief Executive Officer and Director

 

Date: June 15, 2026

 

 

ATTACHMENTS / EXHIBITS

EX-99.1

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• From “visiting a factory” to “stepping into the future”: Kunshan’s industrial tours offer a new way of learning
• CGX Energy Files June 30, 2026 Financial Statements and Announces Changes to the Board of Directors
• Anderson Bradshaw Tax Consulting Expands Tax Resolution Focus as IRS Penalty Relief Changes Encourage Earlier Action